Biotricity ( (BTCY) ) has released a notification of late filing.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Biotricity Inc., a company based in Redwood City, California, has filed a Form 12b-25 to notify the delay in submitting its Form 10-Q (Quarter Report) for the financial period ending December 31, 2024. The delay is primarily due to challenges in completing and obtaining necessary financial information for the report, which the company could not resolve without unreasonable effort and expense. Biotricity expects to file the Form 10-Q within the five-calendar-day extension allowed under the rule. The company does not anticipate any significant changes in its financial results for this period. Biotricity remains committed to compliance, as indicated by the signature of its CEO, Waqaas Al-Siddiq, on the notification.
More about Biotricity
YTD Price Performance: 25.81%
Average Trading Volume: 50,789
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $9.58M
For an in-depth examination of BTCY stock, go to TipRanks’ Stock Analysis page.
